These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20799545)

  • 1. Surveillance of adverse events following immunization: 10 years' experience in Oman.
    Al Awaidy S; Bawikar S; Prakash KR; Al Rawahi B; Mohammed AJ
    East Mediterr Health J; 2010 May; 16(5):474-80. PubMed ID: 20799545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of adverse events following immunization in Oman, 2006-2015.
    Patel PK; Al-Rawahi B; Al-Jawari A; Al-Abaidani I; Al-Abri S
    East Mediterr Health J; 2018 May; 24(2):119-126. PubMed ID: 29748940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
    Schumacher Z; Bourquin C; Heininger U
    Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
    Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
    Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual report on surveillance of adverse events following immunisation in Australia, 2006.
    Lawrence GL; Aratchige PE; Boyd I; McIntyre PB; Gold MS
    Commun Dis Intell Q Rep; 2007 Sep; 31(3):269-82. PubMed ID: 17974219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
    Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
    Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance of adverse events following childhood immunization in Singapore.
    Thoon KC; Soh SB; Liew WK; Gunachandran A; Tan NW; Chong CY; Yung CF
    Vaccine; 2014 Sep; 32(39):5000-5. PubMed ID: 25045811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting of adverse events following immunization in Australia.
    Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J
    J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.